Université Victor Segalen Bordeaux 2
12
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
33%
4 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
E Test Strips Applied to Bronchoalveolar Lavage for Suspicion of Hospital-acquired Pneumonia to Accelerate Antibiogram Analysis.
Role: lead
Tracheal Dosage of Amylase : a New Surrogate for Microaspirations in Ventilated ICU Patients
Role: lead
Determinants of Cognitive Impairment After Acute Coronary Syndrome
Role: collaborator
Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful?
Role: lead
Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease
Role: collaborator
Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome
Role: lead
Phosphorylation of ERK1/2 in Patients With Parkinson's Disease
Role: collaborator
Maâthermes: Spa Treatment for Overweight and Obesity
Role: collaborator
Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury
Role: lead
Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia
Role: lead
Effect of Phytalgic in Osteoarthritis (OA)
Role: lead
Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria
Role: lead
All 12 trials loaded